Reported promising safety and preliminary efficacy data for REC-617, an oral CDK7 inhibitor, and met primary endpoints and demonstrated encouraging...
NuCalm Donates One-Year Membership to their Mobile App to Help Families Heal from the Trauma of Loss and Displacement WILMINGTON,...
PHILADELPHIA, Feb. 27, 2025 /PRNewswire/ -- The Children's Brain Tumor Network (CBTN) announces the addition of the Carson Leslie Foundation...
Genetic testing can be critical to ensuring the early diagnosis and proper treatment of serious disease for patients of all...
CINCINNATI and EINDHOVEN, Netherlands, Feb. 27, 2025 /PRNewswire/ -- Mammotome, a globally recognized leader in breast care, and Sirius Medical, the...
SpherePX Technology Powers Early Detection and Personalized PreventionFRAMINGHAM, Mass., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Alira Health, a global healthcare...
JERUSALEM, Feb. 27, 2025 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the...
PALO ALTO, Calif., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Orbus Therapeutics, Inc., a private, late-stage biopharmaceutical company focused on the...
The Clinical Study is Expected to Randomize 36 Participants in Cleveland Clinic Abu Dhabi (CCAD) and Three Other Clinical Sites...
MENLO PARK, Calif., Feb. 26, 2025 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect...
NEW YORK, Feb. 26, 2025 /PRNewswire/ -- Let's Win Pancreatic Cancer proudly announces our enhanced patient-centered navigation and two powerful new...
Gene structure information identified by combining Compugen's AI/ML predictive computational discovery platform, Unigen™ with Ultima's UG 100™ sequencing platform to better understand...
Marketing innovator Mr. Gustin to drive LiveWorld’s AI-powered growth Carl Gustin, Chief Strategy & Marketing Officer, SpeciCare Carl Gustin appointed...
Dual AI engines in SmartSpeed Precise SmartSpeed Precise pelvis clinical image SmartSpeed Precise knee clinical image SmartSpeed Precise sinus clinical...
THE WOODLANDS, TX, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical...
Meeting addressed progress and strategic direction for company’s induced mesenchymal stem cell (iMSC) therapy programsCAMBRIDGE, Mass., Feb. 26, 2025 (GLOBE...
David Chemerow David Chemerow OCALA, Fla., Feb. 26, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the...
Strategic Funding Led by Nimbus Synergies, Backed by Merck GHI, to Accelerate AI-Powered CollaborationsVANCOUVER, British Columbia, Feb. 26, 2025 (GLOBE...
SOUTH SAN FRANCISCO, Calif., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering...
Results of IMNN-101 Proof-of-Concept study demonstrate persistent immunogenicity in trial participants and further validate PlaCCine® technology IMNN-101 induced 2- to...